Waltham's Tesaro grabs $100M in cancer drug partnership with Takeda
July 27, 2017 at 09:09 AM EDT
Tesaro's drug, which was approved by the FDA in April, will now be developed and sold in Japan by Takeda. Tesaro is also eligible to receive up to $240 million in milestone payments.
